Home Tags FDA priority review

Tag: FDA priority review

Biotech Stock News (ACAD) (RXII) (REGN) (AZN) (ZSPH)

Acadia Pharmaceuticals (NASDAQ:ACAD) On November 3, 2015 Acadia had announced that the FDA had given its Parkinson's Drug, NUPLAZID, FDA priority review. To understand what...

Biotech Stock News (RXII) (REGN) (SURG) (VRX) (ACAD)

Rxi Pharmaceuticals (NASDAQ:RXII) On August 31, 2015 Rxi announced that the 30-day review period for its IND of RXI-109 for scarring of macular degeneration has...

Biotech Stock News (ISIS)(BAYRY)(ALXN)(GEVA)(LJPC)

Isis Pharmaceuticals (NASDAQ:ISIS) Shares of Isis were up 5% on May 4, 2015 after the company announced that Bayer AG (OTCMKTS:BAYRY) bought a license for...

Biotech News 2/16/15 to 2/20/15

Oncolytics Biotech (ONCY) Shares of Oncolytics gained about 36% on 2/17/15 when it had announced that the company received FDA Orphan Drug Designation status for...

Trovagene (TROV) Stock: Providing New Cancer Treatment Options With Onvansertib

We all know what cancer is. The debilitating, often life-threatening condition can be incredibly difficult to treat. As a result, new therapies...

Reviews

TradeMiner Review: Is It Worth Your While?

There are tons of trading tools out there, but none of them are quite like TradeMiner. The software doesn’t look at your...